Adenocarcinoma of the cervix: Expression and clinical significance of estrogen and progesterone receptors

Cancer

Volumn 79, Issue 3, 1997, Pages 505-512

  Fujiwara, Hisaya ^a   Tortolero Luna, Guillermo ^b   Mitchell, Michele Follen ^b   Koulos, John P ^a   Wright Jr , Thomas C ^a  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

cervical adenocarcinoma; estrogen receptors; progesterone receptors; survival

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADENOCARCINOMA; ARTICLE; CANCER SURVIVAL; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 0031031967     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970201)79:3<505::AID-CNCR12>3.0.CO;2-7     Document Type: Article

References (29)

1. Fisher B, Redmond C, Fisher ER, Caplan R. Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-0006. J Clin Oncol 1988;6:1076-87.
2. Creasman WR. Prognostic significance of hormone receptors in endometrial cancer. Cancer 1993;71:1467-70.
3. Gaton E, Zejdel L, Bernstein D, Glezerman M, Czemobilsky B, Insler V. The effect of estrogen and gestagen on the mucus production of human endocervical cells: a histochemical study. Fertil Steril 1982;38:580-5.
4. Masood S, Rhatigan RM, Wilkinson EW, Barwick KW, Wilson WJ. Expression and prognostic significance of estrogen and progesterone receptors in adenocarcinoma of the uterine cervix. An immunocytochemical study. Cancer 1993;72:511-8.
5. Ghandour FA, Attanoos R, Nahar K, Gee JW, Bigrigg A, Ismall SM. Immunocytochemical localization of oestrogen and progesterone receptors in primary adenocarcinoma of the cervix. Histopathology 1994;24:49-55.
6. Petterson F. Annual report on result of treatment in gynecologic cancer. Stockholm: International Federation of Gynecologists and Obstetricians (FIGO), 1988.
7. Wright TC, Ferenczy AF, Kurman RJ. Carcinoma and other tumors of the cervix. In: Kurman RJ, editor. Blaustein's pathology of the female genital tract. 4th edition. New York: Springer-Verlag, 1994;279-326.
8. Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkinson EJ. Histological typing of female genital tract tumors. 2nd edition. Berlin: Springer-Verlag, 1994.
9. Happerfield LC, Bobrow LG, Bains R, Miller KD. Peroxidase labelling immunocytochemistry: a comparison of eleven commercially available avidin-biotin systems. Br J Biomed Sci 1993;50:21-6.
10. SPSS. SPSS base system: syntax reference guide release. 5.0. edition. Chicago: SPSS, 1992.
11. Shingleton HM, Gore H, Bradley DH, Soong S-J. Adenocarcinoma of the cervix. I. Clinical evaluation and pathologic features. Am J Obstet Gynecol 1981;139:799-814.
12. Tamimi HK, Figge DC. Adenocarcinoma of the uterine cervix. Gynecol Oncol 1982;13:335-44.
13. Vesterinen E, Forss M, Nieminen U. Increase of cervical adenocarcinoma: a report of 520 cases of cervical carcinoma including 112 tumors with glandular elements. Gynecol Oncol 1989;33:49-53.
14. Chilvers C, Mant D, Pike MC. Cervical adenocarcinoma and oral contraceptives. BMJ 1987;295:1446-7.
15. Hopkins MP, Morley GW. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol 1991;77:912-7.
16. Kjaer SK, Brinton LA. Adenocarcinomas of the uterine cervix: the epidemiology of an increasing problem. Epidemiol Rev 1993;15:486-98.
17. Eifel PJ, Morris M, Oswald MJ, Wharton JT, Delclos L. Adenocarcinoma of the uterine cervix. Prognosis and patterns of failure in 367 cases. Cancer 1990;65:2507-14.
18. Prempree T, Amornmarn R, Wizenberg MJ. A therapeutic approach to primary adenocarcinoma of the cervix. Cancer 1985;56:1264-8.
19. Parazzini F, La Vecchia C. Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol 1990;39:40-6.
20. Attanoos R, Nahar K, Bigrigg A, Roberts S, Newcombe RG, Ismail SM. Primary adenocarcinoma of the cervix. A clinicopathologic study of prognostic variables in 55 cases. Int J Gynaecol Cancer 1995;5:179-86.
21. Saigo PE, Cain JM, Kim WS, Gaynor JJ, Johnson K, Lewis JLJ. Prognostic factors in adenocarcinoma of the uterine cervix. Cancer 1986;57:1584-93.
22. Goodman HM, Buttlar CA, Niloff JM, Welch WR, Marck A, Feuer EJ, et al. Adenocarcinoma of the uterine cervix: prognostic factors and patterns of recurrence. Gynecol Oncol 1989;33:241-7.
23. Girardi F, Fuchs P, Haas J. Prognostic importance of human papillomavirus type 16 DNA in cervical cancer. Cancer 1992;69:2502-4.
24. Nielsen AL. Human papillomavirus type 16/18 in uterine cervical adenocarcinoma in situ and adenocarcinoma. Cancer 1990;65:2588-93.
25. Ireland D, Hardiman P, Monaghan JM. Adenocarcinoma of the uterine cervix: a study of 73 cases. Obstet Gynecol 1985;65:82-5.
26. Hunter RE, Longcope C, Keough P. Steroid hormone receptors in carcinoma of the cervix. Cancer 1987;60:392-6.
27. Potish RA, Twiggs LB, Adcock LL, Prem KA, Savage JE, Leung BS. Prognostic importance of progesterone and estrogen receptors in cancer of the unterine cervix. Cancer 1986; 58:1709-13.
28. Scambia G, Panici PB, Battaglia F, Ferrandina G, Greggi S, Mancuso S. Steroid hormone receptors in carcinoma of the cervix: lack of response to an antiestrogen. Gynecol Oncol 1990;37:323-6.
29. Martin JD, Hahnel R, McCartney AJ, De Merk M. The influence of estrogen and progesterone receptors on survival in patients with carcinoma of the uterine cervix. Gynecol Oncol 1986;23:329-35.